CIK 0001054102 · Non-accelerated filer<br>Smaller reporting company
INTERPACE BIOSCIENCES, INC.
Sign in to watch- Ticker
- IDXG
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222919486
- Phone
- 412-224-6100
- Business address
- WATERVIEW PLAZA, SUITE 310, 2001 ROUTE 46, PARSIPPANY, NJ, 07054
- Former names
- Interpace Diagnostics Group, Inc., PDI INC, PROFESSIONAL DETAILING INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +105,360 | 105,360 | ||
| 2018-12-05 | STOVER JACK E President and CEO | Grant or award | +87,000 | 340,378 | ||
| 2018-12-05 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +348,000 | 348,000 | ||
| 2018-12-05 | Early James Chief Financial Officer | Grant or award | +3,000 | 17,000 | ||
| 2018-12-05 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2018-12-05 | Richard Gregory Chief Commerical Officer | Grant or award | +13,400 | 44,641 | ||
| 2018-12-05 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +53,600 | 53,600 | ||
| 2018-12-05 | Early James Chief Financial Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2018-12-05 | Richard Gregory Chief Commerical Officer | Grant or award · Stock Option (right to buy) | +67,000 | 67,000 | ||
| 2018-12-05 | STOVER JACK E President and CEO | Grant or award | +60,000 | 313,378 | ||
| 2018-12-05 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +375,000 | 375,000 | ||
| 2018-03-07 | SULLIVAN STEPHEN J Director | Grant or award | +4,800 | 24,583 | ||
| 2018-03-07 | SULLIVAN STEPHEN J Director | Grant or award · Stock Option (right to buy) | +19,200 | 19,200 | ||
| 2018-03-07 | STOVER JACK E President and CEO | Grant or award | +56,000 | 75,738 | ||
| 2018-03-07 | STOVER JACK E President and CEO | Grant or award · Stock Option (right to buy) | +224,000 | 224,000 | ||
| 2018-03-07 | KEEGAN JOSEPH D Director | Grant or award | +4,800 | 17,569 | ||
| 2018-03-07 | KEEGAN JOSEPH D Director | Grant or award · Stock Option (right to buy) | +19,200 | 19,200 | ||
| 2018-03-07 | Schnoll-Sussman Felice Director | Grant or award | +4,800 | 4,800 | ||
| 2018-03-07 | Schnoll-Sussman Felice Director | Grant or award · Stock Option(right to buy) | +19,200 | 19,200 | ||
| 2018-03-07 | Richard Gregory Chief Commerical Officer | Grant or award | +28,000 | 31,241 |
Page 5 of 8 · 158 trades